Clinical Trial 47712

Las Vegas, NV 89102


20 week double blind study followed by a 52 week open label extension, to evaluate the safety and efficacy of a potential new treatment in patients with pain associated with trigeminal neuralgia. 

Qualified Participants Must:

• Be 18-75 years old
• Be diagnosed with trigeminal neuralgia and have pain
• Be willing to discontinue current pain medications

Qualified Participants May Receive:

study related care at no cost

compensation for time and travel


Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.